02:00 Thu 14 Nov 2019
Verona Pharma plc: PDMR Dealing – Purchase by Chairman
Following the purchases,
Further information is provided below in accordance with the requirements of the EU Market Abuse Regulation.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1 | Details of the person discharging managerial responsibilities/person closely associated | |
a) | ||
2 | Reason for the notification | |
a) | Position/status | Chairman |
b) | Initial notification/Amendment | Initial notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | ||
b) | LEI | 213800EVI6O6J3TIAL06 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||
a) | Description of the financial instrument, type of instrument | Ordinary Shares of | ||
Identification code | GB00BYW2KH80 | |||
b) | Nature of the transaction | |||
c) | Price(s) and volume(s) | Date | Price(s) | Volume(s) |
25,000 | ||||
25,000 | ||||
25,000 | ||||
d) | Aggregated information | 75,000 Ordinary Shares | ||
- Aggregated volume | ||||
- Price | ||||
e) | Dates of the transactions | As per 4c) above | ||
f) | Place of the transactions |
For further information, please contact:
Tel: +44 (0)20 3283 4200 | |
info@veronapharma.com | |
N+1 Singer (Nominated Adviser and | Tel: +44 (0)20 3283 4200 |
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE